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Background: Cortical myoclonus with ataxia has only rarely been reported in association with Coeliac Disease (CD).
Such reports also suggested that it is unresponsive to gluten-free diet. We present detailed electro-clinical characteristics
of a new syndrome of progressive cortical hyperexcitability with ataxia and refractory CD. At our gluten/neurology clinic
we have assessed and regularly follow up over 600 patients with neurological manifestations due to gluten sensitivity.
We have identified 9 patients with this syndrome.
Results: All 9 patients (6 male, 3 female) experienced asymmetrical irregular myoclonus involving one or more limbs
and sometimes face. This was often stimulus sensitive and became more widespread over time. Three patients had a
history of Jacksonian march and five had at least one secondarily generalised seizure. Electrophysiology showed
evidence of cortical myoclonus. Three had a phenotype of epilepsia partialis continua at onset. There was clinical,
imaging and/or pathological evidence of cerebellar involvement in all cases. All patients adhered to a strict gluten-free
diet with elimination of gluten-related antibodies in most. However, there was still evidence of enteropathy in all,
suggestive of refractory celiac disease. Two died from enteropathy-associated lymphoma and one from status
epilepticus. Five patients were treated with mycophenolate and one in addition with rituximab and IV immunoglobulins.
Their ataxia and enteropathy improved but myoclonus remained the most disabling feature of their illness.
Conclusions: This syndrome may well be the commonest neurological manifestation of refractory CD. The clinical
involvement, apart from ataxia, covers the whole clinical spectrum of cortical myoclonus.
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The term gluten-related disorders (GRD) encompasses a
spectrum of intestinal and extra-intestinal manifestations
that are immune-mediated and triggered by gluten in-
gestion [1]. Neurological manifestations are increasingly
recognised with gluten ataxia (GA) being the best char-
acterized entity [2]. Unlike GA, ataxia with myoclonus
and celiac disease (CD) is a rare entity first reported in
1966 [3].
A subsequent case report [4], described a patient with
CD, ataxia and tremor of the eyelids, chin and palate.
The pathology showed cerebellar cortical atrophy and
cell loss in dentate and olivary nuclei. Another report [5]
described a patient with established CD, cerebellar ataxia* Correspondence: p.sarrigiannis@sheffield.ac.uk;
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article, unless otherwise stated.and widespread myoclonus with neuropathological evi-
dence of Purkinje cell loss.
In 1986 Lu and colleagues published two cases with ac-
tion myoclonus, ataxia and CD who in addition had
epilepsy [6]. The authors provided electrophysiological evi-
dence for the cortical origin of the myoclonus. Similar
findings of action, stimulus sensitive, cortical myoclonus
were subsequently reported in another patient [7]. This pa-
tient had cortical reflex and action myoclonus resembling
epilepsia partialis continua, with constant arrhythmic myo-
clonic activity in the right hypothenar muscles. Electro-
physiology confirmed the cortical origin of the myoclonus.
The largest case series was published in 1995 [8] and
reported 4 patients with myoclonus and ataxia with
electrophysiological evidence of stimulus sensitive myo-
clonus of cortical origin. Pathology showed atrophy of
the cerebellar hemispheres with Purkinje cell loss. CD
was diagnosed in all four, preceding the onset of the
neurological manifestations by years. Further individualtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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large series.
Such patients unlike those with gluten ataxia appear to
be poorly responsive to gluten-free diet and follow a pro-
gressive course. The type of enteropathy (i.e. refractory
versus gluten responsive), the serological characterization
and any response to immunosupression has never been in-
vestigated or reported.
At the gluten/neurology clinic of our institution (Royal
Hallamshire Hospital, Sheffield, UK) we have assessed
and regularly follow up over 600 patients with neuro-
logical manifestations of GRD. We have identified 9 pa-
tients with this syndrome confirming that this is rare
entity but possibly under-diagnosed. In this report we
outline the electro-clinical and imaging findings (includ-
ing MR spectroscopy), bowel histology and serological
findings as well as our experience with immunosuppres-
sive and symptomatic treatment.
Patients underwent EEG and polygraphic surface EMG
recordings, SEPs, assessment for C-reflexes and jerk-
locked back averaging (JLBA). The latter was performedTable 1 Clinical and electrophysiological findings in 9 patient
Age*
Sex Clinical features of myoclonus
1 50/M EPC right face and tongue (5-6 Hz). Episodes of Jacksonian march,
spreading from face into platysma and right shoulder, occasionally
leading to secondary generalised tonic-clonic seizures. EPC
attenuated during sleep.
2 60/F Continuous myoclonic tremor at around 5 Hz of the right arm.
Occasional myoclonus of the right leg. The left arm developed
asynchronous (5-7 Hz) myoclonic tremor at a later stage. A single
secondary generalised seizure.
3 63/M Continuous myoclonic jerks/action myoclonus of the right UL (5 H
Two years later, deterioration with facial twitching and prominent
action myoclonus (R leg)
4 53/M Very frequent irregular spontaneous, action and reflex myoclonic
tremor of left UL. Later on, episodes of Jacksonian march and
secondary generalisation.
5 76/M Irregular myoclonic action tremor of both ULs (L > R). Spontaneou
and reflex myoclonic tremor of the intrinsic hand muscles (L > R
at ~5-6 Hz).
6 46/F Irregular spontaneous but mainly action and reflex myoclonic
tremor of both UL and LL.
7 61/M Myoclonic status epilepticus with twitching of L UL and LL.
8 52/F Spontaneous, action and reflex myoclonus of ULs (L > R at ~10 Hz
9 74/M Mainly action and reflex myoclonus of LLs (L > R at ~ 4 Hz)
CD = coeliac disease, EEG = electroencephalogram, EPC = epilepsia partialis continua
reflexes, NCS = nerve conduction studies, PLED = periodic lateralised epileptiform di
UL = upper limb, LL = lower limb.
*Age at onset of neurological manifestations.based on previously published studies [11,12] and the
SEPs in line with recent reccomandations [13]. A sum-
mary of the clinical features of the myoclonus and the
neurophysiological findings are found in Table 1. Further
clinical, serological and histopathological (duodenal biopsy)
data is summarised in Table 2.
Results
Clinical characteristics
There were 9 patients (6 men, 3 women). Unlike previ-
ous case reports in all but 2 of our patients the neuro-
logical dysfunction was the initial presentation that lead
to the diagnosis of CD. The mean age at onset of the
neurological symptoms was 59 years (range 46–76). Un-
like myoclonic ataxia (e.g. in the context of opsoclonus
myoclonus ataxia syndrome) the myoclonic tremor in
these patients was initially focal (face, tongue one arm
and/or one leg) but then spread to affect other parts of
the body. Epilepsy was a feature in 5 of the patients, 3 of
which gave a history of Jacksonian march before pro-
gression to generalised seizures. However, only 3 of thes with myoclonic ataxia and Coeliac disease
Electrophysiology
Normal EEG, SEPs, no LLRs. JLBA, revealed that right facial/tongue
twitching was EPC (Figure 2). Normal blink reflex studies and no signs
of denervation on affected facial and tongue muscles. Ten years from
onset of neurological symptoms, axonal PN on EMG & NCS.
Standard EEG unremarkable, SEPs (only left hand) within normal
limits. JLBA, cortical myoclonic tremor of right UL (Additional file 1:
Figure S1). JLBA at a later stage revealed cortical myoclonic tremor
on the left UL. Normal NCS.
z). Mild excess of widespread theta and occasionally delta range
activity, maximal in the temporal and centrotemporal regions. JLBA,
continuous cortical myoclonus (right hand). ‘Giant’ SEPs, right leg,
but no LLR (Additional file 2: Figure S2). Normal NCS.
JLBA, spontaneous and action induced cortical myoclonus. Giant
SEPs from ULs with LLRs, better formed on the right, clinically less
affected side (Figure 4).
s JLBA, cortical origin of the very frequent spontaneous myoclonus of
the right intrinsic hand muscles and forearm. Low amplitude LLR
from left UL (Additional file 2: Figure S2). NCS & EMG, axonal
sensorimotor PN.
‘Giant’ cortical SEPs and LLRs from both median and the right tibial
nerves. JLBA, cortical origin of spontaneous and action induced
myoclonus (Figure 4).
Standard EEG, PLEDs in the right posterior quadrant with irregular
not time-locked asynchronous myoclonic jerks of the left upper and
lower limb. JLBA, cortical generator for the myoclonus (Figure 1).
). JLBA, spontaneous and action induced cortical myoclonus. ‘Giant’
SEPs from both ULs (L > R) and LLRs (Figure 4).
JLBA, mainly action and reflex cortical myoclonus. ‘Giant’ SEPs only
from left LL plus LLRs (Additional file 3: Figure S3).
, EMG = electromyography, JLBA = jerk-locked back averaging, LLR = long loop
scharge, PN = peripheral neuropathy, SEP = somatosensory evoked potentials,
Table 2 Summary of serological and histopathological characteristics of the 9 patients
Case Age/sex Gluten related antibodies
baseline
Gluten related antibodies on
strict gluten-free diet
Duodenal biopsy
baseline
Duodenal biopsy on diet
(duration on diet in years)
EMA TG2 AGA TG6 EMA TG2 AGA TG6
1 50/M n/a n/a n/a n/a -ve -ve -ve -ve Enteropathy Enteropathy (10), EAL
2 60/F +ve n/a +ve IgG pos -ve -ve -ve -ve Enteropathy Enteropathy (5), type 1
3 63/M +ve +ve +ve IgG, IgA pos -ve -ve -ve -ve Enteropathy Enteropathy (3), type 1
4 53/M n/a n/a n/a n/a -ve -ve -ve -ve Enteropathy Enteropathy (10), type 2
5 76/M +ve +ve +ve IgA pos -ve -ve -ve -ve Enteropathy Enteropathy (2), type 1
6 46/F +ve +ve n/a n/a +ve -ve +ve IgG -ve Enteropathy Enteropathy (2), type 1
7 61/M +ve +ve +ve IgG, IgA n/a -ve +ve +ve IgG -ve Enteropathy Enteropathy (1), type 1
8 52/F -ve +ve +ve IgG, IgA pos -ve +ve +ve IgG,IgA -ve Enteropathy Enteropathy (1), type 1
9 74/M +ve +ve n/a n/a -ve -ve +IgA -ve Enteropathy Enteropathy (1.5), type 1
EMA = endomysium antibodies.TG2 = transglutaminase antibodies type 2. AGA = antigliadin antibodies. TG6 = transglutaminase antibodies type 6. EAL = enteropathy
associated lymphoma. Enteropathy = triad of villous atrophy, crypt hyperplasia and increased intraepithelial lymphocytes. Type 1 enteropathy = refractory enteropathy.
Type 2 enteropathy = refractory enteropathy with abnormal intraepithelial T cells.
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patient who presented with status epilepticus (Figure 1).
Seizures were thus not a prominent feature and responded
well to medication. All patients had a mild degree of limb
and more prominent gait ataxia. This is in contrast to pa-
tients with GA where cerebellar ataxia is a very prominent
and the presenting feature. Two patients developed axonal
sensorimotor neuropathy. Gastrointestinal symptoms (in-
cluding diarrhoea, weight loss, abdominal pain) were
prominent in only 2 patients, in whom the diagnosis of
CD was made prior to their neurological presentation.
Imaging findings
All patients underwent MRI scans including MR spec-
troscopy (7 patients) of the cerebellum (vermis and
hemispheres). Mild cerebellar atrophy was noted in 8
patients. Abnormal spectroscopy of the cerebellum (re-
duced NAA/Cr ratio) was seen in all 7 patients who
underwent spectroscopy (these included one patient
with structurally normal cerebellum). In two patients,
following the introduction of immunosuppression, re-
peat spectroscopy improved (increased NAA/Cr). Two
patients had extensive white matter changes in a distri-
bution suggestive of ischemia. The patient who pre-
sented with status epilepticus following the diagnosis of
CD had high signal within the limbic system bilaterally
the aetiology of which was thought to be the status epi-
lepticus. PM examination in this patient showed loss of
Purkinje cells in the cerebellum.
Serological and histological characteristics
All apart from two patients had baseline serological test-
ing, 7 of which showed positivity for endomysium and/
or transglutaminase antibodies (>300 U/ml, normal
range 0–15 U/ml) and 5 positive antigliadin antibodies.
One patient had the biopsy without serological testing.Four baseline samples were available for testing for TG6
antibodies. All 4 were positive. All patients underwent
gastroscopy and duodenal biopsy, 7 of which on more
than one occasion. The baseline histology confirmed the
presence of enteropathy with the triad of villous atrophy,
crypt hyperplasia and increased intraepithelial lympho-
cytes in all 9 patients. Eight patients went on a strict glu-
ten free diet with the mean duration of adherence to the
diet being 3.7 years (range 1–10). One patient has only
just been diagnosed and started the diet. Despite almost
complete elimination of all antibodies repeat biopsies
showed persistent enteropathy in 9 patients (7 refractory
type 1 CD, 2 type 2 refractory CD). None of the above pa-
tients had any serological evidence of voltage gated potas-
sium, calcium, NMDA or paraneoplastic antibodies. Full
autoimmune profile was also normal.
Effect of treatment and final outcome
All but one patient received treatment for their epilepsy
and myoclonus. Medications used included clonazepam
(up to 3 mg/day), sodium valproate (up to 2 g/day), lamo-
trigine (up to 800 mg/day), phenytoin (up to 400 mg/day),
carbamazepine (up to 2 g/day), piracetam (up to 24 g/
day), phenobarbitone (up to 180 mg/day), levetiracetam
(up to 3 g/day), zonisamide (up to 400 mg/day) and more
recently perampanel (up to 4 mg). The epilepsy was suc-
cessfully controlled in all patients (free of secondarily gen-
eralised seizures) using just one of the above medications.
The myoclonus however remained disabling despite max-
imum doses of individual drugs and the use of polyther-
apy. Immunosupression was used in 7 patients. This took
the form of prednisolone and mycophenolate (7 patients).
One patient who continued to progress on mycophenolate
received in addition rituximab and intravenous immuno-
globulins. In 2 patients the introduction of mycophenolate
resulted in improvement of the ataxia both clinically and
Figure 1 Myoclonic status epilepticus (case 7). (A) Routine EEG
while the patient was obtunded and had frequent irregular left
upper and lower limb myoclonic twitches. The surface EMG
electrodes in the left thigh were recording from the quads (upper
trace) and the biceps femoris. In the forearm, surface electrodes
were recording from the extensor digitorum communis (upper
trace) and the finger flexors. EEG tracing shows, about 1 Hz, periodic
lateralized epileptiform discharges in the right posterior quadrant.
Note that these are not time matched to the myoclonic jerks from
the left arm and leg. (B) Jerk-locked back averaging from the left
quads (80 sweeps). There is a time locked negative sharp wave
preceding the onset of the averaged, rectified EMG data by about
25 ms. These recordings were performed in the ICU at a sampling
rate of 500 Hz.
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have only just started mycophenolate. The single patient
who has tried several immunosuppressive treatments with-
out any response remains extremely disabled and wheel-
chair bound due to the myoclonus although her most
recent biopsy shows normalisation of the mucosa. The use
of mycophenolate resulted in normalisation of the bowel
mucosa in another patient. Two patients (both on myco-
phenolate) died, one as a result of biopsy proven meta-
static enteropathy-associated lymphoma, the second with
suspected enteropathy-associated lymphoma. The patientwho presented with status epilepticus died of pneumonia.
He had only received steroids. Recently 2 patients started
perampanel with some significant improvement of their
myoclonus.
Illustrative case history
This fifty-year-old man presented following a leg fracture
after a trivial injury. Bone density scan demonstrated se-
vere osteoporosis with low calcium and vitamin D. Two
months later he noticed a persistent tremor affecting the
right side of his mouth and lips including the tongue. He
reported sudden onset of jaw locking associated with
tongue biting and loss of consciousness. Past medical his-
tory included B12 deficiency.
On examination he had right sided facial twitching
(lower half of the face) involving lips and tongue (Figure 2).
This interfered with his speech. He had mild gait ataxia.
He underwent gastroscopy and duodenal biopsy show-
ing villous atrophy, crypt hyperplasia and increased intrae-
pithelial lymphocytes in keeping with CD. He was started
on a gluten-free diet and phenobarbitone.
A repeat duodenal biopsy performed 6 months later
showed some improvement but persistent increase in the
intraepithelial lymphocytes. In addition to phenobarbitone
he was treated sequentially with sodium valproate, carba-
mazepine, clonazepam, levetiracetam, phenytoin, pirace-
tam and botulinum toxin injections. The most beneficial
interventions were the levetiracetam and the botulinum
toxin injections though the facial twitching was never
completely suppressed. His ataxia completely resolved a
year after the commencement of a gluten-free diet.
He remained stable for the next 10 years apart from
the twitching. He then complained of diarrhoea, weight
loss, poor balance and numbness in his feet. He denied
ingestion of gluten. He continued to have facial tremor
with superimposed episodes of more severe shaking and
jaw locking occurring with a frequency of 4 attacks per
month. Neurological examination revealed lower limb
and gait ataxia with absent ankle reflexes. He had reduc-
tion of sensation in his feet.
Serological testing for CD was negative. Repeat duo-
denal biopsy showed villous atrophy with crypt hyper-
plasia and increased intraepithelial lymphocytes. PAS
staining was negative for Whipple’s disease. MR imaging
showed cerebellar atrophy and low N-acetylaspartate to
creatine ratio of the vermis and cerebellar hemispheres.
CSF examination was normal including PCR for Whipple’s
disease. Whole body PET scan was normal. A diagnosis
of refractory CD type 1 was made. He was started on
mycophenolate.
Reassessment 10 months later showed significant im-
provement of the ataxia. This was associated with signifi-
cant improvement of MR spectroscopy of the vermis
(Figure 3). Antibody testing remained negative. The facial
Figure 2 Epilepsia partialis continua (case 1). (A) Polygraphic EEG and EMG recordings. There is continuous ≈ 5 Hz synchronous rostral and
caudal activation of brainstem innervated muscles. There is a fast rostrocaudal recruitment order, spreading from the upper pons into the bulbar
region. The duration of the EMG discharges is below 50 ms. There are no EEG abnormalities in the central electrodes in the raw EEG recordings.
(B) JLBA from the right OOr (2,100 sweeps) reveals rhythmical cortical correlates in the contralateral central region. They have a positive–negative
morphology – the positive peak preceding the onset of EMG activity by ≈ 15 ms. Mass = Masseter, OOc = orbicularis oculi, OOr = orbicularis
oris, SCM = sternocleidomastoid.
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the right arm. Nine months later he was admitted because
of general malaise and weight loss. He had intermittent
pyrexia with no source of infection. Due to pancytopenia
the mycophenolate was stopped. He was treated empiric-
ally with antibiotics without any benefit. He underwent ex-
tensive investigations including brain MRI, gastroscopy
and duodenal biopsy. There was no evidence of enterop-
athy. MRI showed cerebellar atrophy. PET scan showed
multiple bony lesions suggestive of metastatic carcinoma.
Bone biopsy showed T-cell lymphoma in keeping with
enteropathy-associated lymphoma. He was too unwell to
undergo chemotherapy and passed away a month after
admission.
Discussion
This report represents the largest series of patients with
this unusual phenotype of “hyperexcitable” brain with
cortical myoclonus, ataxia with refractory CD. Contrary
to previous reports, in 7 of our 9 patients CD was diag-
nosed on the basis of their neurological presentation.
We have demonstrated unequivocal electrophysiological
evidence of the cortical origin for the myoclonus. In
addition we presented, for the first time, evidence of re-
fractory CD in all of our patients, with biopsy proven
metastatic enteropathy-associated lymphoma in one and
suspected enteropathy-associated lymphoma in another.
Refractory CD is a rare but well recognised entity that
refers to those patients with CD who no longer respond
to a strict gluten-free diet resulting in persistent symp-
toms of malabsorption and evidence of on-going enter-
opathy on repeat biopsies. It accounts for 10% of all
patients with CD. Refractory CD is divided into 2 types.
Refractory CD type 1 (RCD1) refers to those patients ongluten-free diet who have persistent enteropathy [14].
RCD1 patients often have negative serology for GRD a fact
that distinguishes them from those patients with persistent
enteropathy due to on-going exposure to gluten (dietary
indiscretions). A subgroup of patients has evidence of an
abnormal population of intraepithelial lymphocytes. This
group is designated refractory CD type 2 (RCD2) [15].
Seven of our patients appear to belong to the RCD1 group,
two to RCD2 both of which died of enteropathy-associated
lymphoma. Patients with RCD2 have a higher risk of devel-
oping lymphoma (37%) by comparison to those with
RCD1 (14%). It is unlikely that the neurological manifes-
tations in our patient with biopsy proven metastatic
enteropathy-associated lymphoma represent a paraneo-
plastic phenomenon, as the lymphoma was diagnosed
10 years after the neurological presentation.
RCD is rare as is cortical myoclonus with ataxia. This
suggests that the two conditions are aetiologically linked
rather than occurring by chance. The improvement of the
ataxia following the introduction of gluten-free diet argues
in favour of an aetiological link between the two. The new
evidence for refractory CD, also explains the perception,
from previous case reports, that this condition is unre-
sponsive to gluten-free diet. This is in contrast to other
neurological manifestations of gluten related disorders
such as gluten ataxia (without myoclonus) that have been
shown to be responsive to a strict gluten-free diet. (2)
Whilst the ataxia in some of these patients did improve, it
is the myoclonus that causes persistent disability.
Clinically these patients differ from those with
“myoclonic ataxia” (e.g. mitochondrial diseases, Baltic
myoclonus, opsoclonus myoclonus ataxia syndrome,
Creutzfeld-Jacob disease, post-hypoxia, toxic/metabolic
myoclonus etc.) because their myoclonus is always focal
Figure 3 MR spectroscopy (case1). MR spectroscopy of the vermis before (upper trace) and 10 months after (lower trace) the introduction of
mycophenolate. Patient already on gluten free diet for several years but with refractory coeliac disease (type 2). The NAA peak significantly
increased as did the NAA/Cr (from 0.68 to 0.96). This was associated with clinical improvement of the ataxia.
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to affect other parts of the body. Despite this, it tends to
still remain asymmetric. This is in contrast to what is usu-
ally observed in the aforementioned disorders that can
present with cortical myoclonus and ataxia where myoclo-
nus tends to be more multifocal. In addition unlike gluten
ataxia, the cerebellar ataxia tends to be less prominent
with minimal atrophy on imaging. Three patients from
this group presented at onset with focal, continuous and
spontaneous myoclonus of cortical origin (e.g. Figure 2)
fulfilling the definition of epilepsia partialis continua
[11,16,17]. The focal motor jerks were initially restricted
to one region but became more widespread with time
and had features of cortical myoclonic tremor (Figure 4
and Additional file 1: Figure S1). The clinical variability
seen in this entity included action, noise and stimulus reflex
myoclonus affecting upper and lower limbs (Additional
file 2: Figure S2 and Additional file 3: Figure S3), and epi-
sodes of Jacksonian march spreading from the areas mostaffected by myoclonic jerks, on occasions progressing to
secondarily generalized tonic-clonic seizures.
Immunosuppression with mycophenolate appeared to
help the cerebellar ataxia and in some patients improved
the histological abnormalities on duodenal biopsy. The
most disabling feature, however, remained the myoclonus.
Anticonvulsants did, however prevent secondary general-
ised seizures in all patients who had experienced seizures
at onset. Two of our patients who have recently started
perampanel showed promising improvement of their
myoclonus.
It appears that whatever immunological factors are as-
sociated with refractoriness of the enteropathy are also
likely to be involved in the cortical hyperexcitability.
Neuronal hyperexcitability may not be confined to the
cortex as there is evidence that sensitivity to gluten may
be implicated in another “hyperexcitable” neurological
disease, that of stiff person syndrome [18]. The presence
of TG6 antibodies in all 4 of the baseline samples
Figure 4 Irregular spontaneous, action and reflex myoclonus/myoclonic tremor (cases 4, 6 and 8). (A) ‘Giant’ somatosensory evoked
potentials and C-reflex at a latency of 46 ms after stimulating median nerve at the wrist (case 4). The P1 precedes the C-reflex by 20 ms.
(B) JLBA (245 sweeps) revealed a biphasic spike. There is co-contraction of agonist/antagonist and a proximodistal recruitment order. The EEG
spike precedes the onset of the averaged EMG from the left APB by 20 ms – this is identical to the latency observed between the P1 waveform
on the SEPs and the C-reflex from the APB (C) ‘Giant’ cortical waveforms and C-reflexes in the forearm muscles (latency of 42 ms) after stimulation
of the median nerve at the wrist (case 6). The P1 component of the cortical waveform precedes the onset of the C-reflexes by 17 ms. (D) JLBA
revealed a biphasic cortical correlate preceding the onset of the averaged and rectified EMG discharges (EDC). The latency from the positive EEG
spike to the onset of the averaged EMG is very similar to the one recorded in the SEPs between the P1 component of the cortical waveform and
the long loop responses in the forearm. (E) ‘Giant’ waveforms in the somatosensory evoked potentials (median nerve at the wrist) with prominent
C-reflexes following by 16 ms (EDC) the P1 component of the cortical waveform (case 8). (F) JLBA from the left EDC while left arm at rest. The
averaged data (531 sweeps) show a biphasic cortical correlate in the central region – the positive spike precedes the onset of the averaged EMG
from the EDC by about 17 ms. ADM = abductor digiti minimi, APB = abductor pollicis brevis, EDC = extensor digitorum communis, FCU = flexor
carpi ulnaris, FDS = Flexor digitorum superficialis, SEPs = somatosensory evoked potentials.
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may have a role to play in some of the neurological
manifestation. However, the absence of transglutami-
nase antibodies (including TG6) and other gluten-
related antibodies from the patients’ serum after strict
gluten free diet, argues against these antibodies being
directly involved in the generation of the myoclonus.
This is despite the fact that transglutaminase antibodies
(both TG2 and TG6) have been shown to induce ataxia
in a mouse model [19].
Pathology from post-mortem material has confirmed
that the cerebellum is commonly involved in such cases
[4,8,20]. Additional information obtained from patients
with gluten ataxia suggests that there is loss of Purkinjecells but also evidence of inflammation as indicated by
perivascular cuffing with lymphocytes [8]. In one of our 9
patients where PM material was available, there was indeed
evidence of Purkinje cell loss but no obvious inflammation.
However this patient was already on immunosuppressive
treatment. The role of the cerebellum in the generation of
cortical myoclonus merits some consideration. It has been
suggested that cortical hyperexcitability is due to enhanced
facilitation of the cerebral motor cortex by the cerebellum
[20]. Granule cells enhance activity of Purkinje cells whilst
basket cells inhibit it. A greater relative loss of granule cells
creates a mismatch between excitation and inhibition of
Purkinje cells, with a prevalence of the latter. As a result,
the cerebellar nuclei would be released from the inhibition
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motor cortex from the cerebellar nuclei. Whilst such a
finding has been described in some cases of cortical myo-
clonus (two of which had CD) [20] in our single case
where post mortem material was available we only found
loss of Purkinje cells but intact granule and basket cells.
Furthermore it is unclear why only very few patients with
CD and ataxia will develop cortical hyperexcitability.
Conclusion
These 9 cases illustrate the spectrum of cortical myoclonus
with ataxia seen in refractory CD and reaffirm the concept
that cortical myoclonus is a continuum, ranging from focal
reflex jerks to spontaneous motor epilepsy [11,21].
Based on our experience CD appears to be the com-
monest cause of cortical myoclonus. It is therefore import-
ant to consider CD as a potential diagnosis of all cases
with cortical myoclonus manifesting as myoclonic tremor
and/or epilepsia partialis continua. It is also essential to be
aware of the refractoriness of the enteropathy and the
need for immunosupression.
Methods
All 9 patients were identified initially on clinical and then
neurophysiological grounds from a cohort of over 600
patients regularly attending the gluten/neurology clinic
based at the Royal Hallamshire Hospital, Sheffield UK.
This is an observational study. All the diagnostic tests per-
formed and treatments given were part of routine patient
clinical care. The local ethics committee (Sheffield Teach-
ing Hospitals) has cleared this in writing.
The Xltek EMU128 Headbox (Optima Medical Ltd)
multichannel amplifier was used for EEG and surface
EMG recordings. Sampling frequency of 2 Khz was used.
EMG data was band pass filtered at 50-1000 Hz and EEG
channels at 0.5 – 70 Hz. The stored data used for quanti-
tative analysis, including JLBA did not undergo filtering,
except that initially performed by the amplifier during data
acquisition (0.15 – 940 Hz).
The technique of JLBA was applied based on previous
reports [11,12]. An offline analysis of patient data was
performed by using the data available from the EEG and
EMG polygraphic recordings, after exporting them in
‘EDF’ format. Spike 2 (version 7) software was used to
analyse the data. EMG channels were rectified and DC
removed (time constant 0.05) to allow identification of a
clear onset of the EMG discharges. EEG data was not fil-
tered. This enabled us to be able to record slow pre-
movement cortical potentials that can be seen during
voluntary movements. Events were marked from small
duration (<50 ms) myoclonic jerks, captured from the
surface EMG electrodes. Several hundred to several
thousand events were collected for each patient (range
700–10,000). These events were then used for averaging,JLBA of the EEG and surface EMG polygraphic data. SEP
recordings were made according to recent recommenda-
tions [13]. The presence of C-reflexes was assessed with
additional surface electrodes in the forearm and leg mus-
cles and a single muscle in the hand and foot.Additional files
Additional file 1: Figure S1. Cortical myoclonic tremor (case 2).
(A) EEG and polygraphic recordings with multiple surface EMG electrodes
from the patient’s right upper limb. Continuous myoclonic jerks at a
frequency of ≈ 6 Hz are synchronously affecting proximal and distal
muscles. There is very fast proximodistal recruitment with simultaneous
co-activation of pairs of antagonists. The duration of the EMG discharges
is very short, on average less than 30 ms. (B) JLBA from the right BB.
Two sets of independent averages were superimposed (844 and 648
sweeps were used). A sharp, spiky positive–negative EEG correlate
appears in the contralateral central region, preceding the onset of the
averaged EMG discharges by ≈ 18 ms. APB = abductor pollicis brevis,
BB = biceps brachii, EDC = extensor digitorum communis, FDI = first
dorsal interosseus, FDS = flexor digitorum superficialis, TB = triceps brachii.
Additional file 2: Figure S2. Spontaneous and action myoclonus/
myoclonic tremor (cases 3 and 5). (A) Somatosensory evoked potentials
from the legs (case 3) produced grossly asymmetrical cortical waveforms
(>50%). Prominent action myoclonus was seen on clinical examination,
only from the right leg. However, note the absence of C-reflexes.
(B) JLBA (3000 sweeps) from the right ADM (case 3) shows a biphasic
positive–negative cortical correlate in the contralateral central region.
There is phase reversal around C3 in the bipolar montages. The latency
between the cortical positive spike at C3 and the onset of the EMG bursts
from the ADM is ≈ 23 ms. (C) Electrical stimulation of the left median
nerve at the wrist (case 5) showed normal amplitude cortical waveforms.
There are some low amplitude long loop reflexes appearing in the
forearm flexors and extensors and the abductor pollicis brevis at a latency
of 50 and 55 ms, respectively. The patient is affected by a large fibre
axonal peripheral neuropathy and is 1,91 m tall. Therefore, these latencies
would be in keeping with low amplitude cortical reflexes. (D) A positive
spike appears in the JLBA (4,309 sweeps) in case 5. The positive spike is
maximal in the left frontocentral cortical electrodes, better formed at
F3C3. The peak of the positive spikes precedes the onset of the averaged
EMG discharges from the right APB by ≈ 16 ms, pointing towards a fast
corticospinal transmission. Note the very low amplitude of the positive
spikes (<1 μV). However, these are clearly standing out from the background
due to the high number of averaged sweeps, resulting in very substantial
increase in the signal-to-noise ratio. AH = abductor hallucis, APB = abductor
pollicis brevis, FDI = first dorsal interosseus, EDC = extensor digitorum
communis, GST = gastrocnemious, TA = tibialis anterior.
Additional file 3: Figure S3. Lower limb action and reflex cortical
myoclonus (case 9). (A) Somatosensory evoked potentials after electrical
stimulation of the left posterior tibial nerve. The cortical waveform is
‘Giant’, above 20 μV in amplitude and there are conspicuous long loop
reflexes affecting the lower leg flexor/extensors, with latency from the
electrical stimulus at the ankle of 86 ms. (B) The Jerk-locked back averaging
from the left TA (76 sweeps) shows biphasic, positive/negative EEG spikes,
with the positive spikes lagging behind the onset of the averaged EMG
from the TA by around 30 ms. TA = tibialis anterior, GST = gastrocnemious,
AH = abductor hallucis.Competing interests
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